-
公开(公告)号:US20200268869A1
公开(公告)日:2020-08-27
申请号:US15781035
申请日:2016-12-02
发明人: Shaowei LI , Zhihai LI , Shuo SONG , Maozhou HE , Ying GU , Ningshao XIA
IPC分类号: A61K39/12 , C07K14/005 , C12N7/00 , A61P31/20 , C12N15/70
摘要: Provided are a mutated HPV58 L1 protein or a variant thereof, a sequence encoding the same, a method for preparing the same, and a virus-like particle comprising the same, wherein the protein or a variant thereof and the virus-like particle can induce the generation of neutralizing antibodies against at least two HPV types, and therefore can be used to prevent infection by said at least two HPV types, and a disease caused by said infection, such as cervical cancer and condyloma acuminatum. The invention further relates to the use of the protein and the virus-like particle in the manufacture of a pharmaceutical composition or a vaccine for preventing infection by said at least two HPV types, and a disease caused by said infection, such as cervical cancer and condyloma acuminatum.
-
公开(公告)号:US20240000919A1
公开(公告)日:2024-01-04
申请号:US18252836
申请日:2021-11-12
发明人: Ying GU , Tingting DENG , Hui ZHANG , Fang HUANG , Gege CHEN , Yanling LIN , Shaowei LI , Ningshao XIA
IPC分类号: A61K39/21 , C12N7/00 , C07K14/005 , A61P31/18
CPC分类号: A61K39/21 , C12N7/00 , C07K14/005 , A61P31/18 , C12N2740/16122 , C12N2740/16134 , C07K2319/40 , C12N2740/16171 , A61K2039/645
摘要: Provided are a newly designed HIV-1 Env trimer protein, and an HIV-1 pseudovirus and virus expressing the Env trimer protein, and the use thereof for the prevention and/or treatment of HIV infection.
-
公开(公告)号:US20210228703A1
公开(公告)日:2021-07-29
申请号:US15734670
申请日:2019-06-04
发明人: Shaowei LI , Shuo SONG , Maozhou HE , Jingjie SHI , Ying GU , Ningshao XIA
摘要: The present invention relates to a mutated HPV18 L1 protein (or a variant thereof), a sequence encoding the same, a method for preparing the same, and a virus-like particle comprising the same, wherein the protein (or a variant thereof) and the virus-like particle can induce the generation of neutralizing antibodies against at least two HPV types (for example, HPV18 and HPV45, or HPV18, HPV45 and HPV59), and therefore can be used to prevent infection by said at least two HPV types, and a disease caused by said infection, such as cervical cancer and condyloma acuminatum. The invention further relates to the use of the protein and the virus-like particle in the manufacture of a pharmaceutical composition or a vaccine for preventing infection by said at least two HPV types, and a disease caused by said infection, such as cervical cancer and condyloma acuminatum.
-
公开(公告)号:US20220001002A1
公开(公告)日:2022-01-06
申请号:US17280805
申请日:2019-09-26
发明人: Shaowei LI , Daning WANG , Jie CHEN , Ying GU , Jun ZHANG , Ningshao XIA
IPC分类号: A61K39/12 , C07K14/015 , C12N7/00 , A61P31/20
摘要: Provided are a mutated HPV51 L1 protein or a variant thereof, a coding sequence thereof, a preparation method therefor, and a virus-like particle containing same, wherein the protein or the variant and the virus-like particle thereof are capable of inducing neutralizing antibodies against at least two types of HPV (for example, HPV51 and HPV69, or HPV51, HPV69 and HPV26). Also provided is the use of the above-mentioned protein and the virus-like particle for preparing a pharmaceutical composition or a vaccine, wherein the pharmaceutical composition or the vaccine can be used to prevent infections of the at least two types of HPV and diseases caused by the infections, such as cervical cancer and condyloma acuminatum.
-
公开(公告)号:US20210000938A1
公开(公告)日:2021-01-07
申请号:US16630673
申请日:2018-07-13
发明人: Ying GU , Shaowei LI , Shuo SONG , Maozhou HE , Zhihai LI , Ningshao XIA
摘要: Provided are a mutated HPV16 L1 protein (or a variant thereof), a sequence encoding the same and a method for preparing the same, as well as a virus-like particle comprising the same. The protein (or variant thereof) and the virus-like particle are capable of inducing neutralizing antibodies against at least two types of HPV (e.g., HPV16 and HPV35, or HPV16, HPV35, and HPV31), and therefore can be used to prevent infection by said at least two HPV types, and a disease caused by said infection, such as cervical cancer and condyloma acuminatum. Also provided are a use of the above protein and virus-like particle in the manufacture of a pharmaceutical composition or vaccine for preventing infection by said at least two HPV types, and a disease caused by said infection, such as cervical cancer and condyloma acuminatum.
-
公开(公告)号:US20180207257A1
公开(公告)日:2018-07-26
申请号:US15924511
申请日:2018-03-19
发明人: Jun ZHANG , Jin WANG , Chunyan YANG , Ying GU , Shaowei LI , Ningshao XIA
IPC分类号: A61K39/12 , C12N7/00 , C07K14/005
CPC分类号: A61K39/12 , C07K14/005 , C12N7/00 , C12N2710/20022 , C12N2710/20023 , C12N2710/20034
摘要: The invention relates to a truncated L1 protein of the Human Papillomavirus Type 11, a virus-like particle consisting of the protein, a vaccine comprising said virus-like particle, and the use of the vaccine in the prevention of condyloma acuminatum or HPV infections.
-
-
-
-
-